Select your location.
*e-commerce not available for this region.
The IVISbrite™ PC3 Red-F-luc-GFP tumor cell line (Bioware® Brite PC3-Red-FLuc-GFP) is a light-producing and fluorescent cell line derived from PC3 human prostate adenocarcinoma. The cells have been stably transduced with the red-shifted firefly luciferase gene from Luciola Italica (Red F-luc) fused to GFP (Green Fluorescent Protein), for a brighter, red-shifted bioluminescent or green fluorescent signal.
IVISbrite PC3 Red F-luc-GFP Bioluminescent Tumor Cell line
This cell line has very bright bioluminescence, emitting at least 8,000 photons/cell/sec in vitro. The exact number will vary depending on imaging and culturing conditions.
By emitting intensified, longer wavelength light that is significantly brighter than other firefly luciferases, our bioluminescent oncology cell lines allow you to visualize and monitor the growth of deep tissue tumors in vivo. The GFP fusion also allows for fluorescent imaging in vivo or ex vivo.
After the cells are injected into an appropriate mouse model, the optimized Red F-luc luciferase enables more sensitive in vivo optical detection with less tissue attenuation so you can detect tumor development earlier, and monitor tumor growth and metastases in both subcutaneous and orthotopic models.
|Quantity in a Package Amount
2 vials each containing 1 million cells